Literature DB >> 1771084

A call for more science, not more rhetoric, regarding opioids and neuropathic pain.

Ronald Dubner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1771084     DOI： 10.1016/0304-3959(91)90002-F

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  7 in total

Review 1.  Myopia.

Authors:  Paul N Baird; Seang-Mei Saw; Carla Lanca; Jeremy A Guggenheim; Earl L Smith Iii; Xiangtian Zhou; Kyoko-Ohno Matsui; Pei-Chang Wu; Padmaja Sankaridurg; Audrey Chia; Mohamad Rosman; Ecosse L Lamoureux; Ryan Man; Mingguang He
Journal:  Nat Rev Dis Primers       Date:  2020-12-17       Impact factor: 52.329

Review 2.  Opioids for neuropathic pain.

Authors:  Nathaniel Katz; Christine Benoit
Journal:  Curr Pain Headache Rep       Date:  2005-06

Review 3.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

4.  [Prevalence and characteristics of neuropathic pain in malignant disease.].

Authors:  S Grond; D Zech; T Meuser; L Radbruch; M Kasper; K A Lehmann
Journal:  Schmerz       Date:  1992-06       Impact factor: 1.107

5.  [Slow-release morphine liquid suspension for the therapy of cancer pain and non-cancer pain-A pilot study.].

Authors:  M Strumpf; B Donner; M Zenz
Journal:  Schmerz       Date:  1995-05       Impact factor: 1.107

Review 6.  New developments in the assessment of pain in cancer patients.

Authors:  E Bruera; S Watanabe
Journal:  Support Care Cancer       Date:  1994-09       Impact factor: 3.603

7.  Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?

Authors:  Igor Kissin
Journal:  J Pain Res       Date:  2013-07-04       Impact factor: 3.133
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.